1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Ambrx Biopharma Inc (AMAM)

  7. Ambrx Biopharma Inc (AMAM) News

AMAM

Ambrx Biopharma Inc
10,13
0,00 (0,0%)
Upgrade auf Real-Time
Name Symbol Markt Aktientyp
Ambrx Biopharma Inc AMAM NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,0% 10,13 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
10,13
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.3.202322:14EDGARCertification by the Exchange Approving Securities for..
16.3.202321:37EDGARNotification Filed by a National Securities Exchange to..
16.3.202321:07EDGARStatement of Ownership (sc 13g)
16.3.202321:07EDGARAmended Securities Registration (section 12(b)) (8-a12b/a)
13.3.202321:02EDGARInitial Statement of Beneficial Ownership (3)
13.3.202321:01EDGARAmended Statement of Ownership (sc 13g/a)
13.3.202313:01EDGARCurrent Report Filing (8-k)
08.3.202316:52EDGARStatement of Changes in Beneficial Ownership (4)
08.3.202316:51EDGARInitial Statement of Beneficial Ownership (3)
03.3.202322:11EDGARAmended Statement of Ownership (sc 13g/a)
03.3.202322:07EDGARInitial Statement of Beneficial Ownership (3)
03.3.202322:07EDGARStatement of Ownership (sc 13g)
01.3.202314:12EDGARCurrent Report Filing (8-k)
27.2.202322:06EDGARStatement of Ownership (sc 13g)
14.2.202322:04EDGARAmended Statement of Ownership (sc 13g/a)
14.2.202315:31EDGARAmended Statement of Ownership (sc 13g/a)
13.2.202312:08EDGARAmended Statement of Ownership (sc 13g/a)
09.2.202314:25EDGARAmended Statement of Ownership (sc 13g/a)
01.2.202300:19EDGARStatement of Changes in Beneficial Ownership (4)
01.2.202300:17EDGARStatement of Changes in Beneficial Ownership (4)
01.2.202300:16EDGARStatement of Changes in Beneficial Ownership (4)
01.2.202300:08EDGARStatement of Changes in Beneficial Ownership (4)
10.1.202300:35EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:43EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:41EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:36EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:33EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:31EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:29EDGARInitial Statement of Beneficial Ownership (3)
04.1.202300:07EDGARInitial Statement of Beneficial Ownership (3)
19.12.202214:31EDGARStatement of Ownership (sc 13g)
16.12.202223:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11.12.202218:37TRMNMeet the Biotech Stock That Jumped Over 1000% in One Day
11.12.202218:25TRMNCowen & Co. Keeps Their Buy Rating on Ambrx Biopharma (AMAM)
09.12.202216:36TRMNAMAM Pops After Positive Clinical Trial Data
09.11.202214:00BWAmbrx Announces NovoCodex’s Dosing of First Patient with..
01.11.202221:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
01.11.202221:05BWAmbrx Biopharma Inc. Appoints Daniel O’Connor as Chief..
18.10.202222:35EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
18.10.202222:05GLOBEAmbrx Biopharma Inc. Announces Strategic Reprioritization..
11.10.202222:05GLOBEAmbrx Biopharma to Host Corporate Update Conference Call
23.9.202206:35TRMNRobert W. Baird Sticks to Its Buy Rating for Ambrx Biopharma..
29.8.202222:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
29.8.202222:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
29.8.202222:05BWAmbrx Biopharma Inc. Reports 1H 2022 Financial Results and..
16.8.202222:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
16.8.202222:05BWAmbrx Biopharma Appoints Kate Hermans as Interim CEO,..
08.8.202212:06EDGARNotice of Effectiveness (effect)
05.8.202222:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
05.7.202222:05BWAmbrx Biopharma Appoints Edward Hu and Kate Hermans to its..
Kürzlich von Ihnen besucht
NYSE
AMAM
Ambrx Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Melden Sie sich bei ADVFN an
Jetzt registrieren

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20230328 17:45:24